- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 16/36 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
Patent holdings for IPC class C07K 16/36
Total number of patents in this class: 693
10-year publication summary
|
34
|
41
|
63
|
65
|
72
|
78
|
75
|
60
|
63
|
19
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
46 |
| Genmab A/S | 382 |
26 |
| Novo Nordisk A/S | 2324 |
20 |
| CSL Behring GmbH | 350 |
17 |
| Ablynx N.V. | 377 |
16 |
| CSL Limited | 251 |
16 |
| Merus N.V. | 185 |
16 |
| Takeda Pharmaceutical Company Limited | 2961 |
15 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
15 |
| Bayer Pharma AG | 1096 |
14 |
| Oregon Health & Science University | 746 |
14 |
| Merck Sharp & Dohme LLC | 3689 |
12 |
| Adimab, LLC | 134 |
10 |
| Kymab Limited | 229 |
10 |
| Zymeworks Inc. | 234 |
10 |
| Novartis AG | 11238 |
9 |
| F. Hoffmann-La Roche AG | 7958 |
9 |
| Alexion Pharmaceuticals, Inc. | 606 |
9 |
| Aronora, Inc. | 15 |
9 |
| Genmab B.V. | 53 |
9 |
| Other owners | 391 |